~~<i id='D1040CA84C'><strike id='D1040CA84C'><tt id='D1040CA84C'><pre id='D1040CA84C'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

leisure time

author：entertainment 2025-08-23 06:47:14 - browse：356

Trump Campaign Event In Nevada — Ethan Miller/Getty Images

WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Ukraine seeks to reclaim its role as a hub for clinical trials

hotspot

leisure time

focus

hotspot

knowledge

SadieJames,right,andJonTaylor,adebtmanageratthecharityChristiansAgainstPoverty,readthedocumentsfroma

WSS

Flagship Pioneering startup Sonata Therapeutics lays off 21

BridgeBio heart drug succeeds in pivotal study

New study raises questions about niacin and heart health

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Researchers tackle phage therapy hurdles for wider adoption

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

explore

leisure time

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Opioid cravings were reduced by anti

In age of alternative facts, a scholarly course on calling out crap

ER docs worry over extreme heat as a 'mass casualty event'

Continuity nursing helped my family in our darkest PICU moments

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Bright Health sells Medicare Advantage business to Molina

House passes resolution saying Israel isn't a 'racist or apartheid state'

State Dept. review finds Biden bears some blame for Afghanistan failures

Researchers tackle phage therapy hurdles for wider adoption

leisure time

Twill hunts for pharma partner to market its depression app

FDA warns medical device makers about rise in fabricated data

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Study: Hearing aids may slow cognitive decline in those at risk

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Lack of darker skin in textbooks, journals harms patients of color

focus

hotspot

hotspot

knowledge